Marc Stapley, Chief Executive Officer of Veracyte, Inc. (VCYT), executed a significant sale of company shares on June 4, 2026. Stapley sold 138,051 shares at an average price of $50.12 per share, a transaction valued at approximately $6.92 million.
This sale represents a notable disposition of stock by a key executive. Other Veracyte insiders, including Rebecca Chambers and Annie McGuire, also reported selling shares on the same day.
Insider sales can be driven by various factors, including portfolio diversification, tax obligations, or pre-arranged trading plans. Such transactions do not necessarily reflect a negative outlook on the company's future performance.